FUSOGENIX
PIPELINE
ABOUT
NEWS
CONTACT
News and Publications
October 1, 2019
Entos Pharmaceuticals Announces Research, Development and Collaboration Agreement
Published by:
Entos Pharmaceuticals
September 5, 2019
Entos Pharmaceuticals joins JLABS San Diego
Published by:
Entos Pharmaceuticals
July 8, 2019
Precision Nanosystems and Entos Pharmaceuticals sign license agreement
Published by:
PRESS RELEASE (Precision NanoSystems)
October 1, 2019
IPA and Entos to Collaborate on Immuno-oncology Discovery Research
Published by:
Entos
July 2, 2018
Entos awarded entry into the Merck Invention Accelerator
Published by:
Entos Pharmaceuticals
March 30, 2018
Entos and Oisin Bio Announce Fusogenix License for SENSOlytics™
Published by:
Entos Pharmaceuticals
June 26, 2018
Entos and Oisin Bio Launch OncoSenX: A Spinoff Company Targeting Cancer
Published by:
John D. Lewis, PhD
Entos Pharmaceuticals
Unit 4550, 10230 Jasper Avenue
Edmonton, Alberta, Canada
T5J 4P6
Email:
info@entospharma.com
Phone:
1-780-862-7445
Name
Email Address
Company Name
Message
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
